Evidence map›Paper›PMID 35180003›Full record

ArticleCancer control : journal of the Moffitt Cancer Center

Determination of Serum Prostate Specific Antigen Levels Amongst Apparently Healthy Nigerian Males in a University and University Hospital Community in the Federal Capital Territory.

Oseremen I Aisuodionoe-Shadrach, Sefiu B Eniola, Maxwell M Nwegbu, Hadijat O Kolade-Yunusa, Oriaku O Okereke, Thairu Yunusa

Open access · goldAbstract read
In one paragraph

Article in Cancer control : journal of the Moffitt Cancer Center. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Prostate cancer in Nigeria: a scoping review and meta-analysis of current evidence on process indicators and interventions.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology · 2025
    Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Oseremen I Aisuodionoe-ShadrachDepartment of Surgery, College of Health Sciences, 99399University of Abuja, Abuja, Nigeria.
Sefiu B EniolaDivision of Urology, Department of Surgery, University of Abuja Teaching Hospital, Gwagwalada, Nigeria.ORCID https://orcid.org/0000-0003-3868-9993
Maxwell M NwegbuDepartment of Chemical Pathology, College of Health Sciences, 99399University of Abuja/ University of Abuja Teaching Hospital, Gwagwalada, Nigeria.ORCID https://orcid.org/0000-0002-6768-8546
Hadijat O Kolade-YunusaDepartment of Radiology, 291366University of Abuja/University of Abuja Teaching Hospital, Gwagwalada, Nigeria.
Oriaku O OkerekeUniversity Health Services, 99399University of Abuja, Abuja, Nigeria.
Thairu YunusaDepartment of Microbiology, 291366University of Abuja/University of Abuja Teaching Hospital, Gwagwalada, Nigeria.
University of Abuja Teaching Hospital · NGUniversity of Abuja · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundProstate cancer is the commonest cancer among men worldwide and serum prostate specific antigen (PSA) has remained the most commonly applied screening test for the disease till date. Current PSA test results guidelines in our population are informed by reference intervals derived from studies from Caucasians and other racial groups. With scanty data on PSA reference values from our local population, this study evaluated the serum PSA levels of apparently healthy Nigerian male subjects in whom prostate cancer and urinary tract infection have been excluded.

methodThis study had participants aged 40 to 70 years, with no lower urinary tract symptoms or other symptoms suggestive of prostate disease recruited from the male staff population of the University of Abuja and University of Abuja Teaching Hospital and the adjoining local community. They were physically examined, had prostate ultrasonography, urine analysis, and blood sample collected for PSA testing. Data collected was analyzed using Statistical Package for Social Science (SPSS) version 24.

resultOf a total of 210 men who participated in the study, 191 eventually met the inclusion criteria. The average age was 52.9 years, ninety seven percent of them had heard of prostate cancer before now. The mean total PSA was 1.46 ng/mL (SD +/-1.55), while the reference interval was .23-5.60 ng/mL. The average prostate size was 41.8 mL (SD+/-20.11), and there was a positive correlation between the PSA and the prostate size (.418) as well as the age of the subjects (.446). There was no significant difference in the mean PSA value for those with or without family history of prostate cancer (

conclusionThe reference range of PSA in Nigeria is higher than in other races, hence utilizing a local value in decision making would help to reduce unnecessary invasive procedures.

Indexed as

Prostate-Specific AntigenProstatic NeoplasmsAdultAgedAge FactorsHospitalsHumansMaleMiddle AgedNigeriaProstateProstate-Specific Antigenblacksinterval rangeNigeriaprostate cancerprostate-specific antigenreference

Identifiers

PMID35180003
PMCPMC8859665
OpenAlexW4213210339

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.